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Abstract 
Export of glutathione S-conjugate of bimane (BSG) was studied in human erythrocytes. Characteristics of the BSG transport is similar 
to that of dinitrophenyl-S-glutathione (DNP-SG). BSG transport has two kinetic components, one of high affinity and low capacity 
(K m = 7.4 _ 0.2 /~mol/ml ce]lls, V m = 2.7 ___ 0.1 nmol/min per ml RBC) and another of low affinity and high capacity (K m = 242 ___ 8 
/xmol/ml cells, V m = 9.6 + 1.6 nmol/min per ml RBC). BSG export is inhibited by vanadate (K i = 65 ___ 6 ~M) and fluoride 
( K i = 11.4 + 0.8 mM). Activation energy of the transport is 67 + 7 kJ/mol. BSG transport is independent of membrane potential; its rate 
increases with pH in the pH range of 6-8, in line with the assumption that the anionic onjugate is cotransported with proton. BSG import 
to erythrocyte membrane inside-out vesicles is stimulated by ATP. Fluorimetric measurements of BSG export require low amounts of 
cells and may also be useful for other cell types as an alternative to studies of glutatione S-conjugate transport using radioactive 
substrates. 
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1. Introduction 
Glutathione conjugation is an important step in the 
detoxication pathway of many xenobiotics. It is a well- 
established phenomenon that such conjugates are exported 
from many cell types by means of active transport [1,2]. 
Erythrocytes are a good model system for the explanation 
of such processes since their lack of y-glutamyltrans- 
peptidase precludes further metabolising of formed conju- 
gates. Indeed, the existence of primary active transport of 
glutathione conjugates was first proven in human erythro- 
cytes and erythrocyte membrane inside-out vesicles [3-5]. 
The compound most widely used in such studies is 2,4-di- 
nitrophenyl-S-glutathione (DNP-SG), formed from 1- 
chloro-2,4-dinitrobenzene (CDNB) in a reaction catalysed 
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by glutathione-S-transferase. Th  transport of this molecule 
through erythrocyte membrane has been investigated in 
detail, mostly using inside-out membrane vesicles and 
radiolabelled DNP-SG [4,6-9]. Some work has also been 
carried out on export of DNP-SG from intact erythrocytes 
upon incubation with CDNB [3,5,10-13]. Such a system 
does not, however, provide a very handy tool for kinetics 
research, since variation of intracellular DNP-SG level is 
difficult and cannot be achieved in a wide range of concen- 
trations. DNP-SG in the extracellular fluid is determined 
spectrophotometrically (absorption wavelength 336-340 
nm), so the method is not very sensitive and its reliability 
has been disputed because of the possibility of other 
compounds in the supernatant contributing to the ab- 
sorbance value [5], while it requires large amounts of 
blood. In view of this being a reliable method of determin- 
ing the activity of the putative glutathione conjugate trans- 
porter in intact erythrocytes, using spectrofluorimetric de- 
terminations which are more sensitive and allowing for 
wider concentration range variations while requiring much 
less cells, would be more useful. Moreover, a sensitive 
fluorimetric method of monitoring the export of glu- 
tathione S-conjugates could provide a convenient non-iso- 
tope alternative for studies of other cells, available in 
lower quantities than erythrocytes. Research on organic 
anion transport in intact erythrocytes i bound to provide 
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more valuable insights into mechanism and kinetics in 
vivo, since vesicle preparation i variably causes ignificant 
membrane structure and function disturbance and, investi- 
gating the membrane separately from the rest of the cell, 
one can never be sure of the physiological relevance of 
results thus obtained. 
Halogenobimanes (chlorobimane and bromobimane) are 
highly reactive non-fluorescent compounds which can serve 
as effective labels since they react with thiol groups of 
organic molecules, forming highly fluorescent adducts [ 14]. 
It is an established fact that, under physiological condi- 
tions, upon incubation with erythrocytes, they enter the 
cells and react with intracellular glutathione, forming an 
S-conjugate (bimane-S-glutathione, BSG). Whereas mono- 
bromobimane (mBBr) is a rather promiscuous SH reagent, 
reacting with many intracellular thiols (e.g., proteins), 
monochlorobimane (mBCI) is supposed to be rather spe- 
cific for glutathione [15], although this has recently been 
disputed [16]. Active BSG extrusion was proposed for 
human peripheral blood mononuclear cells, but the phe- 
nomenon was not investigated in detail [16]. We also 
studied BSG transport from yeast S. cerevisiae cells (in 
preparation). Erythrocytes eem to be a more convenient 
model for organic anion transport studies than other types 
of cells because of their structure simplicity, easy han- 
dling, relatively high intracellular glutathione concentra- 
tion and glutathione S-transferase activity. We found that, 
like other glutathione-S-conjugates, BSG is also actively 
exported from the human erythrocyte, and we describe 
hereby some of the kinetic properties of this process. 
2. Materials and methods 
Blood was obtained from healthy donors (young males) 
by venipuncture upon informed consent. Erythrocytes were 
collected after centrifugation at3000 X g for 5 min, washed 
3 times with PBS (150 mM NaC1, 10 mM phosphate 
buffer, pH = 7.4) and used within 24 h. Monochlorobi- 
mane (mBC1) was from Molecular Probes (Eugene, USA), 
and all other reagents were from Sigma (Deisenhofen, 
Germany) and were of analytical grade. 
All given values are means ( _ S.D.) of triplicate xperi- 
ments. 
BSG transport hrough erythrocyte membranes. Human 
erythrocytes, uspended at 50% hematocrit in buffer Z 
(138 mM NaC1, 5 mM KC1, 1 mM MgC12, 10 mM 
glucose, 8 mM phosphate buffer, pH = 7.4), were incu- 
bated for 5 min with 10/xM mBC1 (mBC1 was added from 
a stock solution of 10 mM in ethanol) at room temperature. 
Then they were washed once, suspended to 2% hematocrit 
in buffer Z and incubated at 37°C. After specified time 
intervals aliquots were withdrawn, centrifuged and super- 
natant was added to ice-cold 10% TCA for hemoglobin 
removal (hemoglobin was shown to effectively quench 
BSG fluorescence; data not shown). Hemolysis was 
checked and it was always below 1%. Nevertheless, a 
correction of each fluorescence value for BSG released by 
hemolysis (based on the determination of the amount of 
released hemoglobin from absorbance at 540 nm) was 
made. Fluorescence of the aliquots was measured in a 
Perkin-Elmer LS-5B fluorescence spectrophotometer at ex- 
citation wavelength of 386 nm and emission wavelength of 
476 nm. 
The dependence of fluorescence intensity on BSG con- 
centration was found to be linear for BSG concentrations 
up to 5 /zM, so molar fluorescence coefficients could be 
calculated for specific spectrophotometer slit settings and 
they could be used for expressing the data collected in 
non-arbitrary absolute units. The influence of internal filter 
effect can be ruled out, because during deproteination all 
the samples were diluted, so a concentration of BSG larger 
than 5 ~M has never been measured in the course of this 
study. 
Membrane potential was varied by the addition of 1 
/zm/ml valinomycin in media of variable K + concentra- 
tion (modified buffer Z in which various fractions of NaCI 
were substituted for by KC1). The membrane potential in 
these conditions was calculated from the Nernst equation 
[17]. 
Erythrocyte membrane vesicles were prepared from hu- 
man erythrocyte membranes by a modified method of 
Steck and Kant [18]. The modification consisted of the 
employment of 0.5 mM Tris-HC1 buffer (pH = 8.0), in- 
stead of a phosphate buffer, and the inclusion of 300 mM 
sucrose in the vesiculation medium to compensate the 
osmolality of media used during transport studies. Percent- 
age of inside-out vesicles in the preparation was deter- 
mined by the acetylcholinesterase ccessibility assay. Vesi- 
cles (protein concentration of 0.5 mg/ml)  were incubated 
for 30 min at 37°C with 200 /xM BSG (obtained by 
nonenzymatic conjugation of mBC1 to glutathione) in the 
presence of 2 mM ATP, 10 mM phosphocreatine, 200 
U/ml  creatine kinase (control sample - without ATP), 
centrifugated at 20000 x g, washed twice with 300 mM 
sucrose, lysed with water and the fluorescence of the 
sample was measured. 
3. Results and discussion 
Properties of BSG export from human erythrocytes. It 
was shown that, upon incubation of human erythrocytes 
with mBC1, a fluorescent compound is excreted from the 
cells to the medium in a time-dependent manner. This 
compound was identified as bimane-glutathione conjugate 
(BSG) by means of thin-layer chromatography on Silicagel 
60 (Merck, Darmstadt). The Rf of the fluorescent com- 
pound, exported from erythrocytes (visualised under a UV 
lamp), was identical to the Rf of BSG obtained by unenzy- 
matical conjugation of mBCI to glutathione in two differ- 
ent mobile phase solvent systems (n-propanol:acetic 
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acid:H20 10:1:5 and isopropanol:H20 9:1; Rf = 0.64 and 
0.45, respectively). The time course of BSG excretion was 
shown to be linear for 15 min for the conditions described 
in Section 2 (Fig. l) and up to 60 min for larger mBC1 
concentrations. This process appears to be an ATP-requir- 
ing active transport, since metabolic ATP-depletion of 
erythrocytes (by incubating them for 24 h at 37°C) dramat- 
ically inhibited it (Table 1). 
The transport rate under conditions described was 77 _+ 
l0 (n = 18) nmol conjugate transported per ml of erythro- 
cytes per hour. 
In order to characterize the kinetic properties of the 
transport system, intracellular BSG concentration was var- 
ied by using different mBC1 concentrations. Lineweaver- 
Burk plot of the data (Fig. 2) suggested the existence of 
two distinct ransport components, just as it is well-docu- 
mented in case of DNP-SG transport. The respective ki- 
netic parameter values for those two components were: 
K m = 7.4 + 0.2 /zmol/ml  cells and 242 + 8 /zmol /ml  
cells and Vma x = 2.7 + 0.1 nmol /min  per ml RBC and 
9.6 + 1.6 nmol /min  per m] RBC. The maximal transport 
velocity values can be compared only to the values given 
for DNP-SG transport in intact erythrocytes. Both values 
Table 1 
Inhibition of BSG export from human erythrocytes by different com- 
pounds and treatments 
Agent or treatment BSG transport Percentage of 
[nmol/h per ml RBC] control transport 
Control (n = 18) 77 + 10 100 
Metabolic depletion 6.5 + 1 8 
Vanadate 10 ~M 69 + 10 89 
Vanadate 50/.~M 46 _ 4 60 
Vanadate 100/xM 11.6+0.8 15 
Vanadate 200/xM 2.3 + 1.3 3 
Fluoride 5mM 60 + 9 78 
Fluoride 10 mM 44+7 57 
Fluoride 20 mM 22 + 5 29 
NEM 1 /xM 45+12 58 
NEM 5/~M 12 +4 16 
NEM 20/xM 0.2 + 0.06 0.3 
DIDS 10/xM 74+3 96 
SITS 20/xM 70+8 91 
are higher than the ones reported by Eckert and Eyer for 
DNP-SG export (0.9 and 4.5 nmol /min /ml  respectively 
[11]). The K m value for low-affinity BSG export appears 
low in comparison to the values obtained for DNP-SG 
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Fig. 1. Time course of BSG export from human erythrocytes. Erythrocytes were incubated at50% hematocrit with 10 /.~M mBCI for 5 min, washed, 
suspended to hematocrit 2% in buffer Z and incubated at 37°C. After stated time intervals aliquots were withdrawn and their fluorescence was measured. 
The extracellular concentration f BSG was calculated from the previously measured dependence of fluorescence intensity on concentration. Data 
presented asmean + S.D. (n = 3). 
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import to inside-out vesicles (940 /xM [4], 1600 /xM [8], 
897/xM [9]) and intact erythrocytes (700 /xM [11]), while 
the value for the high-affinity component is higher for 
BSG than for DNP-SG (the values for DNP-SG being 3.9 
/xM [8] and 2.7/xM [9] for inside-out vesicles and 1.4/xM 
[11] for intact erythrocytes). 
BSG import into erythrocyte membrane inside-out vesi- 
cles. The vesicle sample incubated with BSG in the pres- 
ence of ATP was five times higher than the sample 
without ATP (data not shown). This proves that the trans- 
port system requires ATP. 
Inhibition of BSG transport. A wide array of known 
organic anion transport inhibitors were tested for inhibitory 
action in the studied system. It was found that vanadate 
strongly inhibited this transport with IC50 of 65 ___ 6 /xM 
(Table 1). Vanadate, an inhibitor of P-type ATPases [19], 
inhibits potently many active organic anion transport sys- 
tems, the erythrocyte glutathione conjugate pump included 
[8,10]. Likewise the fluoride ions did inhibit BSG efflux 
with IC50 of 11.4___ 0.8 mM (Table I). The fluoride 
inhibition of glutathione conjugate transport has been ex- 
plained diversely: as a result of cellular energy depletion 
[5,11] or due to direct interactions with the transporter 
molecule [8]. Since the fluoride concentrations which in- 
hibit glutathione conjugate transport are higher than mag- 
nesium ions concentration i  the medium, it is feasible that 
this agent acts by depleting cellular magnesium contents. 
N-ethylmaleimide, an SH-group reagent, also inhibited 
BSG transport (IC50 = 1.4 ___ 0.2 /xM, Table 1). This indi- 
cates that the transporter polypeptides has some sulfhydryl 
group(s) which are vital for the activity. Inhibition of 
glutathione conjugate transport through uman erythrocyte 
membranes by NEM has been demonstrated before for 
DNP-SG transport [4]. Known Band 3 anion exchanger 
inhibitors DIDS and SITS had no effect on the investigated 
process (Table 1). Band 3 protein can catalyse passive 
organic anion diffusion, but these results clearly show this 
is not the case with BSG (nor with other glutathione 
conjugates [manuscript submitted]). 
We observed pronounced competitive inhibition of BSG 
transport by intracellular DNP-SG after incubation with 
CDNB (data not shown), but the results obtained were 
difficult to interpret unequivocally because of possible 
competition at the level of glutathione-S-transferase and 
BSG fluorescence quenching by DNP-SG. 
Some other organic anions, notably 2,4-dinitrophenol 
(DNP) and carbonylcyanide phenylhydrazones, were re- 
cently shown to stimulate a membrane ATPase activity 
ascribed to the glutathione conjugate transporter [20]. It 
was therefore of interest o check the influence of those 
agents on glutathione conjugate transport in vivo, as exem- 
plified by BSG transport. In our experiments we used DNP 
and carbonylcyanide 3-chlorophenylhydrazone (CCCP), the 
latter compound being an oxidative phosphorylation un- 
coupler homologous to carbonylcyanide 4-trifluorometho- 
xyphenylhydrazone (FCCP) used by Winter et al. and 
likewise stimulating erythrocyte membrane Mg2+-ATPase 
activity (unpublished). In the experiments conducted with 
the concentrations u ed by Winter et al. [20], which in 
their model competed with DNP-SG for erythrocyte mem- 
brane ATPase stimulation, we did not detect any signifi- 
cant changes in BSG transport. Slight inhibition of the 
process could be seen with markedly higher concentrations 
of the organic anions (Table 2). This finding can be 
interpreted as consistent with the hypothesis that these 
organic anions are substrates for the glutathione conjugate 
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Fig. 2. Lineweaver-Burk plot of BSG export from human erythrocytes. Data presented as mean + S.D. (n = 3). 
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Table 2 
Influence of RBC membrane ATPase-stimulating agents on BSG export 
from human erythrocytes 
BSG transport Percentage of 
[nmol/h per ml RBC] control transport 
Control 76 + 2 100 
DNP 50/xM 75 + 6 99 
DNP 200/xM 71 +8 94 
DNP 1000/xM 55+11 72 
CCCP 5 p.M 76-t-3 100 
CCCP 10/xM 75-t-4 99 
CCCP 20/zM 74+ 10 96 
CCCP 50/zM 53 + 3 69 
Table 3 
Influence of extracellular sodium and potassium concentrations on BSG 
export from human erythrocytes 
Cation proportion i BSG transport Percentage of 
extracellular medium [nmol/h per ml RBC] control transport 
100% Na÷/0% K ÷ 75 +6 100 
97% Na+/7% K ÷ 80+6 106 
67% Na+/33% K+ 73+7 98 
33% Na+/67% K÷ 74+6 98 
7% Na+/97% K÷ 78+7 103 
0% Na÷/100% K÷ 76+5 102 
transporter, bearing in mind that the K m of the high-affin- 
ity BSG transport (measured in this experiment) is much 
lower than the value reported for DNP stimulation of the 
erythrocyte membrane Mg2÷-ATPase (174/xM [20]). This 
could be the cause of DNP ,;howing only limited inhibition 
of BSG transport, even at ihigh concentrations. A similar 
explanation can be given for CCCP, if it interacts more 
weakly than FCCP with the transporter molecule. 
Influence of pH on BSG export. We found that pH of 
extracellular medium during transport has an effect on 
transport rate, which decrea,;ed with lowering the pH in the 
range 8.0-6.0 in a qua-linear pattern (Fig. 3). We obtained 
a highly similar dependence curve for DNP-SG transport 
in intact erythrocytes ( ubmitted). 
Temperature dependence of BSG transport. By deter- 
mining the transport velocity at different incubation tem- 
peratures (in the range 25--42°C), we were able to con- 
struct an Arrhenius plot for the transport process and to 
calculate the apparent actiwttion energy, which was 67 _ 7 
kJ /mol.  These data stand in good congruence with the 
ones obtained for DNP-SG transport in erythrocyte mem- 
brane vesicles, where the activation energy for the low-K m 
and high-K m processes were 51 + 6 k J /mol  and 61 +__ 5 
kJ /mol,  respectively [9], and they conform even better to 
the data of Eckert and Eyer (activation energy 70 k J /mol  
for DNP-SG transport by intact erythrocytes [11]). 
Extracellular cation concentration and membrane po- 
tential influence on BSG transport. Measuring the trans- 
port activity in media containing different proportions of 
K ÷ to Na ÷, we found a lack of influence of these cations 
availability on BSG export (Table 3). Similar results were 
obtained by Kondo et al. [4] for DNP-SG transport by 
inside-out vesicles, although the lack of cation requirement 
has not been positively proven. Likewise, incubating the 
erythrocytes with different potassium concentrations in the 
presence of valinomycin, which leads to changes in mem- 
brane potential, did not have any effect on the BSG 
transport (Table 4). This provides a strong argument against 
the glutathione conjugate transport system being coupled 
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Fig. 3. pH dependence of BSG export from human erythrocytes. Data presented as mean + S.D. (n = 3). 
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Table 4 
Influence of membrane potential on BSG export from human erythrocyte 
Membrane BSG transport Percentage of 
potential [mV] [nmol/h per ml RBC] control transport 
120 79+4 100 
60 79+8 101 
20 77 + 6 97 
2 78 ___ 11 99 
-6  74+5 93 
- 10 81 + 5 103 
to sodium or potassium ion gradient (for example being a 
symport or antiport system) or being a secondary active 
transport driven by membrane potential, confirming the 
findings of LaBelle et al. [10]. The lack of dependence of
transport parameters on membrane potential implies more- 
over that the transport process is not electrogenic n spite 
of the anionic nature of the conjugate. This could imply 
the possibility of coupling of glutathione conjugate xport 
with the import of some anions (an antiport system) or 
export of cations (a symport system) -e.g., a symport with 
hydrogen ions. The latter possibility could also be inferred 
from the dependence of the transport rate on extracellular 
pH. 
4. Conc lus ions  
The characteristics of BSG transport in human erythro- 
cytes strictly resembles that of DNP-SG in ATP require- 
ment, biphasic kinetics, effects of inhibitors, activation 
energy, pH dependence and lack of dependence on mem- 
brane potential. BSG can be easily monitored fluorimetri- 
cally; it may be a useful means of studying the transport of 
glutathione S-conjugates in erythrocytes and in other cell 
types. 
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